oxybutynin is a Oral Tablet, Film Coated, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Remedyrepack Inc.. The primary component is Oxybutynin Chloride.
| Product ID | 70518-2331_93ced2f0-ebb2-02f7-e053-2a95a90a59be |
| NDC | 70518-2331 |
| Product Type | Human Prescription Drug |
| Proprietary Name | oxybutynin |
| Generic Name | Oxybutynin |
| Dosage Form | Tablet, Film Coated, Extended Release |
| Route of Administration | ORAL |
| Marketing Start Date | 2019-09-30 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA202332 |
| Labeler Name | REMEDYREPACK INC. |
| Substance Name | OXYBUTYNIN CHLORIDE |
| Active Ingredient Strength | 10 mg/1 |
| Pharm Classes | Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2019-09-30 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA202332 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-09-30 |
| Ingredient | Strength |
|---|---|
| OXYBUTYNIN CHLORIDE | 10 mg/1 |
| SPL SET ID: | d2a33b1a-7739-4057-b258-eac835200173 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0615-8219 | oxybutynin | oxybutynin |
| 0615-8220 | Oxybutynin | Oxybutynin |
| 50090-5352 | oxybutynin | oxybutynin |
| 50090-5353 | oxybutynin | oxybutynin |
| 68382-255 | oxybutynin | oxybutynin |
| 68382-256 | oxybutynin | oxybutynin |
| 68382-257 | oxybutynin | oxybutynin |
| 70518-1457 | oxybutynin | oxybutynin |
| 70518-2331 | oxybutynin | oxybutynin |
| 70771-1086 | oxybutynin | oxybutynin |
| 70771-1087 | oxybutynin | oxybutynin |
| 70771-1088 | oxybutynin | oxybutynin |
| 71335-0974 | oxybutynin | oxybutynin |
| 0023-6153 | OXYTROL | Oxybutynin |
| 52544-920 | OXYTROL | Oxybutynin |
| 0023-9637 | Oxytrol for Women | Oxybutynin |
| 52544-166 | Oxytrol For Women | oxybutynin |